• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核细胞在骨髓增殖性肿瘤发病机制中的作用

Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.

作者信息

Li Xuedong, Xu Mingli, Wang Yingying

机构信息

Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.

Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing 400016, China.

出版信息

Int J Mol Sci. 2025 Jul 3;26(13):6422. doi: 10.3390/ijms26136422.

DOI:10.3390/ijms26136422
PMID:40650198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12250554/
Abstract

Classical BCR-ABL-negative myeloproliferative neoplasms are a heterogeneous group of hematologic malignancies, including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. Monocytes, immune cells derived from hematopoietic stem cells, exhibit significant heterogeneity and contribute to immune regulation through cytokine secretion and differentiation into dendritic cells and macrophages. Aberrant monocytes are associated with the prognosis of MPNs, particularly PMF. Furthermore, these altered monocytes play a critical role in the pathogenesis and progression of MPNs. This review aims to explore the heterogeneity of different monocyte subsets during homeostasis and focuses on the potential mechanisms by which monocytes contribute to the development and progression of MPNs.

摘要

经典的BCR-ABL阴性骨髓增殖性肿瘤是一组异质性血液系统恶性肿瘤,包括原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化。单核细胞是源自造血干细胞的免疫细胞,具有显著的异质性,并通过细胞因子分泌以及分化为树突状细胞和巨噬细胞来参与免疫调节。异常单核细胞与骨髓增殖性肿瘤的预后相关,尤其是原发性骨髓纤维化。此外,这些改变的单核细胞在骨髓增殖性肿瘤的发病机制和进展中起关键作用。本综述旨在探讨稳态期间不同单核细胞亚群的异质性,并着重研究单核细胞促进骨髓增殖性肿瘤发生和发展的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0526/12250554/730e6b0d49cf/ijms-26-06422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0526/12250554/730e6b0d49cf/ijms-26-06422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0526/12250554/730e6b0d49cf/ijms-26-06422-g001.jpg

相似文献

1
Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.单核细胞在骨髓增殖性肿瘤发病机制中的作用
Int J Mol Sci. 2025 Jul 3;26(13):6422. doi: 10.3390/ijms26136422.
2
Chinese Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes.中国BCR::ABL1阴性骨髓增殖性肿瘤患者:髓系单核细胞的免疫表型
Int J Lab Hematol. 2025 Aug;47(4):698-706. doi: 10.1111/ijlh.14461. Epub 2025 Mar 16.
3
Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population.摩洛哥人群中 BCR-ABL1 阴性骨髓增殖性肿瘤的分子特征。
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):4013-4025. doi: 10.31557/APJCP.2024.25.11.4013.
4
Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia.骨髓增殖性肿瘤与浆细胞异常并存。
Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):31-6. doi: 10.1016/j.clml.2013.09.015. Epub 2013 Sep 30.
5
BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.BCR-ABL阴性骨髓增殖性肿瘤:相关分子机制综述
Histol Histopathol. 2015 Feb;30(2):151-61. doi: 10.14670/HH-30.151. Epub 2014 Sep 5.
6
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.JAK2V617F骨髓增殖性肿瘤中中性粒细胞清除缺陷通过免疫检查点CD24驱动骨髓纤维化。
Blood. 2025 Aug 7;146(6):717-731. doi: 10.1182/blood.2024027455.
7
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature.青少年和年轻成人人群中的骨髓增殖性肿瘤:文献综述。
Br J Haematol. 2024 Jul;205(1):48-60. doi: 10.1111/bjh.19557. Epub 2024 Jun 10.
8
Crossing Barriers Cancer Model for Studying Monocyte Migration across Endothelial Barriers.用于研究单核细胞跨内皮屏障迁移的跨屏障癌症模型
ACS Biomater Sci Eng. 2025 Aug 11;11(8):5038-5050. doi: 10.1021/acsbiomaterials.5c00783. Epub 2025 Jul 17.
9
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.骨髓增殖性肿瘤的发病率有多高?一项系统评价和荟萃分析。
Am J Hematol. 2014 Jun;89(6):581-7. doi: 10.1002/ajh.23690.
10
Inheritance of the chronic myeloproliferative neoplasms. A systematic review.慢性骨髓增殖性肿瘤的遗传。系统综述。
Clin Genet. 2013 Feb;83(2):99-107. doi: 10.1111/cge.12044. Epub 2012 Nov 20.

本文引用的文献

1
Clinical Characteristics, Prognostic Factors, and Thrombotic and Bleeding Outcomes in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Single-Center Cohort Study in Thailand.费城染色体阴性骨髓增殖性肿瘤的临床特征、预后因素以及血栓形成和出血结局:泰国一项单中心队列研究
Cureus. 2025 Apr 12;17(4):e82141. doi: 10.7759/cureus.82141. eCollection 2025 Apr.
2
Emerging roles of SLAMF7 in immune cells and related diseases.信号淋巴细胞激活分子家族成员7(SLAMF7)在免疫细胞及相关疾病中的新作用。
Innate Immun. 2025 Jan-Dec;31:17534259251326700. doi: 10.1177/17534259251326700. Epub 2025 Mar 16.
3
The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders.
CS1(信号淋巴细胞激活分子家族成员7)在免疫调节中的多方面作用:对癌症治疗和自身免疫性疾病的影响。
Exp Cell Res. 2025 Apr 1;447(1):114516. doi: 10.1016/j.yexcr.2025.114516. Epub 2025 Mar 10.
4
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.核糖体S6激酶1(RSK1)是骨髓增殖性肿瘤和继发性急性髓系白血病中一个可利用的依赖性因素。
Nat Commun. 2025 Jan 16;16(1):492. doi: 10.1038/s41467-024-55643-7.
5
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.达雷妥尤单抗难治性多发性骨髓瘤的结局和预后指标:一项针对247例患者使用埃罗妥珠单抗、泊马度胺和地塞米松的多中心真实世界研究。
ESMO Open. 2025 Feb;10(2):104084. doi: 10.1016/j.esmoop.2024.104084. Epub 2025 Jan 7.
6
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.TIE2激酶抑制剂瑞巴斯替尼联合紫杉醇或艾瑞布林用于HER2阴性转移性乳腺癌的Ib期临床及药效学研究。
Clin Cancer Res. 2025 Jan 17;31(2):266-277. doi: 10.1158/1078-0432.CCR-24-2464.
7
Different inflammatory, fibrotic, and immunological signatures between pre-fibrotic and overt primary myelofibrosis.纤维化前期和明显原发性骨髓纤维化之间不同的炎症、纤维化和免疫特征。
Haematologica. 2025 Apr 1;110(4):938-951. doi: 10.3324/haematol.2024.285598. Epub 2024 Oct 10.
8
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN).标题:Fedratinib 联合 Nivolumab 治疗对 JAK 抑制剂治疗有抵抗或疗效不佳的骨髓纤维化患者的 II 期研究方案:德国 MPN 研究小组(GSG-MPN)
Ann Hematol. 2024 Aug;103(8):2775-2785. doi: 10.1007/s00277-024-05867-w. Epub 2024 Jul 5.
9
Myeloproliferative Neoplasms Transcriptome Reveals Pro-Inflammatory Signature and Enrichment in Peripheral Blood Monocyte-Related Genes.骨髓增殖性肿瘤转录组揭示了促炎特征,并在外周血单核细胞相关基因中富集。
Cancer Invest. 2024 Aug;42(7):605-618. doi: 10.1080/07357907.2024.2371371. Epub 2024 Jul 3.
10
Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering.采用全光谱流式细胞术和层次标记聚类对人单核细胞亚群进行全面分析。
Front Immunol. 2024 Apr 29;15:1405249. doi: 10.3389/fimmu.2024.1405249. eCollection 2024.